- Home
- Publications
- Publication Search
- Publication Details
Title
Combination immunotherapies for type 1 diabetes mellitus
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume 11, Issue 5, Pages 289-297
Publisher
Springer Nature
Online
2015-02-17
DOI
10.1038/nrendo.2015.8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell Replacement Strategies Aimed at Reconstitution of the β-Cell Compartment in Type 1 Diabetes
- (2014) Giuseppe Orlando et al. DIABETES
- Citrullinated Glucose-Regulated Protein 78 Is an Autoantigen in Type 1 Diabetes
- (2014) Dieter Rondas et al. DIABETES
- Evaluation of Long-Term Treatment Effect in a Type 1 Diabetes Intervention Trial: Differences After Stimulation With Glucagon or a Mixed Meal
- (2014) Paolo Pozzilli et al. DIABETES CARE
- Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes
- (2014) Ronnie Aronson et al. DIABETES CARE
- The New insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes
- (2014) Yunjuan Zhao et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Pancreatic Pathology in Type 1 Diabetes Mellitus
- (2014) Sarah J. Richardson et al. ENDOCRINE PATHOLOGY
- Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Maintains β-Cell Function in Patients With Recent-Onset Latent Autoimmune Diabetes in Adults: One Year Prospective Study
- (2014) Yunjuan Zhao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Application of Clinical Judgment and Guidelines to Achieving Glycemic Goals in Type 2 Diabetes: Focus on Pharmacologic Therapy
- (2014) Tamer G. Yacoub POSTGRADUATE MEDICINE
- Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial
- (2014) Kurt J Griffin et al. Lancet Diabetes & Endocrinology
- GLP-1 agonists in type 1 diabetes
- (2013) Jeremy Pettus et al. CLINICAL IMMUNOLOGY
- Posttranslational Modification of HLA-DQ Binding Islet Autoantigens in Type 1 Diabetes
- (2013) M. van Lummel et al. DIABETES
- Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
- (2013) K. C. Herold et al. DIABETES
- C-Peptide Levels in Latent Autoimmune Diabetes in Adults Treated With Linagliptin Versus Glimepiride: Exploratory Results From a 2-Year Double-Blind, Randomized, Controlled Study: Table 1
- (2013) Odd Erik Johansen et al. DIABETES CARE
- Infectious triggers in type 1 diabetes: is there a case for epitope mimicry?
- (2013) G. Afonso et al. DIABETES OBESITY & METABOLISM
- Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study
- (2013) A. Barker et al. DIABETES OBESITY & METABOLISM
- Proposal for generating new beta cells in a muted immune environment for type 1 diabetes
- (2013) Claresa Levetan et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain
- (2013) Angels Mollo et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- Type 1 diabetes
- (2013) Mark A Atkinson et al. LANCET
- The use of stem cells for pancreatic regeneration in diabetes mellitus
- (2013) Luc Bouwens et al. Nature Reviews Endocrinology
- The current state of pancreas transplantation
- (2013) Rainer W. G. Gruessner et al. Nature Reviews Endocrinology
- Stimulating β-Cell Regeneration by Combining a GPR119 Agonist with a DPP-IV Inhibitor
- (2013) Ansarullah et al. PLoS One
- Addition of Rapamycin to Anti-CD3 Antibody Improves Long-Term Glycaemia Control in Diabetic NOD Mice
- (2013) Shira Perl et al. PLoS One
- TNF-Like Weak Inducer of Apoptosis (TWEAK) Promotes Beta Cell Neogenesis from Pancreatic Ductal Epithelium in Adult Mice
- (2013) Fei Wu et al. PLoS One
- Immunologic and Metabolic Biomarkers of -Cell Destruction in the Diagnosis of Type 1 Diabetes
- (2013) J. Lebastchi et al. Cold Spring Harbor Perspectives in Medicine
- Dipeptidyl peptidase-4 inhibitors: Multitarget drugs, not only antidiabetes drugs (D ipeptidyl peptidase -4抑制剂:多靶点药物,不仅仅是降糖药)
- (2013) Yunjuan Zhao et al. Journal of Diabetes
- Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial
- (2013) Mark R Rigby et al. Lancet Diabetes & Endocrinology
- Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial
- (2013) Stephen E Gitelman et al. Lancet Diabetes & Endocrinology
- Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs -Cell Function
- (2012) S. A. Long et al. DIABETES
- Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data
- (2012) C. J. Greenbaum et al. DIABETES
- Combined treatment with a dipeptidyl peptidase-IV inhibitor (sitagliptin) and an angiotensin II type 1 receptor blocker (losartan) promotes islet regeneration via enhanced differentiation of pancreatic progenitor cells
- (2012) J. Liang et al. DIABETES OBESITY & METABOLISM
- Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β-cell mass in a streptozotocin-induced mouse model of type 2 diabetes
- (2012) S. M. Poucher et al. DIABETES OBESITY & METABOLISM
- Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study
- (2012) D. Dabelea et al. DIABETOLOGIA
- Treatment of autoimmune diabetes in NOD mice by Toll-like receptor 2 tolerance in conjunction with dipeptidyl peptidase 4 inhibition
- (2012) D.-H. Kim et al. DIABETOLOGIA
- HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus
- (2012) R. Strollo et al. DIABETOLOGIA
- Effects of 12 weeks’ treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study
- (2012) K. D. Hove et al. DIABETOLOGIA
- Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial
- (2012) K. C. Herold et al. DIABETOLOGIA
- Effect of Sitagliptin on Post-Prandial Glucagon and GLP-1 Levels in Patients With Type 1 Diabetes: Investigator-Initiated, Double-Blind, Randomized, Placebo-Controlled Trial
- (2012) Satish Garg et al. Endocrine Practice
- Pantoprazole Improves Glycemic Control in Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2012) Pawan Kumar Singh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dipeptidyl Peptidase IV Inhibition Does Not Adversely Affect Immune or Virological Status in HIV Infected Men And Women: A Pilot Safety Study
- (2012) Scott R. Goodwin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice
- (2012) Jacob Jelsing et al. JOURNAL OF ENDOCRINOLOGY
- Proton Pump Inhibitor Therapy Associated with Lower Glycosylated Hemoglobin Levels in Type 2 Diabetes
- (2012) M. A. Crouch et al. Journal of the American Board of Family Medicine
- GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus
- (2012) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination Therapy with a Dipeptidyl Peptidase-4 Inhibitor and a Proton Pump Inhibitor Induces β-Cell Neogenesis from Adult Human Pancreatic Duct Cells Implanted in Immunodeficient Mice
- (2011) Wilma L. Suarez-Pinzon et al. CELL TRANSPLANTATION
- Synergistic Reversal of Type 1 Diabetes in NOD Mice With Anti-CD3 and Interleukin-1 Blockade: Evidence of Improved Immune Regulation
- (2011) V. Ablamunits et al. DIABETES
- C-Peptide Response and HLA Genotypes in Subjects With Recent-Onset Type 1 Diabetes After Immunotherapy With DiaPep277
- (2011) Raffaella Buzzetti et al. DIABETES
- Effects of Exenatide on Measures of -Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes
- (2011) M. C. Bunck et al. DIABETES CARE
- Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial
- (2011) S. L. Ellis et al. DIABETIC MEDICINE
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- Heterogeneity of T1DM raises questions for therapy
- (2011) Paolo Pozzilli Nature Reviews Endocrinology
- Proinsulin, GLP-1, and glucagon are associated with partial remission in children and adolescents with newly diagnosed type 1 diabetes
- (2011) Anne Kaas et al. PEDIATRIC DIABETES
- The Stunned β Cell: A Brief History
- (2010) Ele Ferrannini Cell Metabolism
- Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group
- (2010) J. B. Matthews et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
- (2010) M. Peakman et al. DIABETES
- Failure to Preserve -Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New- Onset Type 1 Diabetes
- (2010) P. A. Gottlieb et al. DIABETES CARE
- Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients - a retrospective analysis
- (2010) Karin D. Hove et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Reversal of New-Onset Diabetes through Modulating Inflammation and Stimulating β-Cell Replication in Nonobese Diabetic Mice by a Dipeptidyl Peptidase IV Inhibitor
- (2010) Lei Tian et al. ENDOCRINOLOGY
- Chromogranin A is an autoantigen in type 1 diabetes
- (2010) Brian D Stadinski et al. NATURE IMMUNOLOGY
- Stem cell therapy for type 1 diabetes mellitus
- (2010) Cristina Aguayo-Mazzucato et al. Nature Reviews Endocrinology
- The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into α and Subsequently β Cells
- (2009) Patrick Collombat et al. CELL
- Generation of Novel Single-Chain Antibodies by Phage-Display Technology to Direct Imaging Agents Highly Selective to Pancreatic - or -Cells In Vivo
- (2009) S. Ueberberg et al. DIABETES
- No Effect of the Altered Peptide Ligand NBI-6024 on -Cell Residual Function and Insulin Needs in New-Onset Type 1 Diabetes
- (2009) M. Walter et al. DIABETES CARE
- Challenges in developing endpoints for type 1 diabetes intervention studies
- (2009) Simona Cernea et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice
- (2009) W. L. Suarez-Pinzon et al. DIABETOLOGIA
- 11C-Dihydrotetrabenazine PET of the Pancreas in Subjects with Long-Standing Type 1 Diabetes and in Healthy Controls
- (2009) R. Goland et al. JOURNAL OF NUCLEAR MEDICINE
- Proton pump inhibitors as a treatment method for type II diabetes
- (2009) Ivan N. Mefford et al. MEDICAL HYPOTHESES
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination Therapy with Glucagon-Like Peptide-1 and Gastrin Induces β-Cell Neogenesis from Pancreatic Duct Cells in Human Islets Transplanted in Immunodeficient Diabetic Mice
- (2008) Wilma L. Suarez-Pinzon et al. CELL TRANSPLANTATION
- Combination Therapy With Glucagon-Like Peptide-1 and Gastrin Restores Normoglycemia in Diabetic NOD Mice
- (2008) W. L. Suarez-Pinzon et al. DIABETES
- Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of -Cell Function in Therapeutic Trials in Type 1 Diabetes
- (2008) C. J. Greenbaum et al. DIABETES CARE
- Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1
- (2008) J. M. Sosenko et al. DIABETES CARE
- Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy
- (2007) M. Chianelli et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now